Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Source BioScience is a leading UK-based laboratory service provider specializing in genomics and histopathology. It offers molecular diagnostics—including next-generation sequencing—and digital pathology solutions with AI integration. The company played a significant role in COVID‑19 PCR testing for the NHS during the pandemic. Its acquisition of LDPath has strengthened its position as a leader in digital cellular pathology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Source BioScience.